Neostigmine Methylsulfate
- Product NDC
- 0517-1134
- 11-digit product format
- 005171134
- Labeler code
- 0517
- Product ID
- 0517-1134_26754034-0eea-4e9d-b89b-017aa3d60ce3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Neostigmine Methylsulfate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- American Regent, Inc.
- Application
- ANDA209182
- Marketing category
- ANDA
- Marketing start
- 2018-05-14
- Marketing end
- 0000-00-00
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0517-1134-05 | 00517113405 | 5 VIAL, MULTI-DOSE in 1 CARTON (0517-1134-05) > 10 mL in 1 VIAL, MULTI-DOSE (0517-1134-01) | 2018-05-14 | 0000-00-00 | No | No | Current |